Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liam R Brunham

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Journal of the American College of Cardiology|September 2, 2017
Optimizing Cholesterol Treatment in Patients With Muscle ComplaintsRobert S Rosenson, Steven Baker, Maciej Banach, et al.
JAMA Oncology|April 28, 2017
Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular CancerBritt I Drögemöller, Jose G Monzon, Amit P Bhavsar, et al.
American Heart Journal|May 5, 2024
Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYNStephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
The Canadian Journal of Cardiology|August 11, 2018
Simplified Canadian Definition for Familial HypercholesterolemiaIsabelle Ruel, Diane Brisson, Sumayah Aljenedil, et al.
Nature Medicine|April 17, 2026
Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trialStephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
Nature Medicine|February 27, 2026
Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trialStephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
Atherosclerosis|June 2, 2026
Homozygous familial hypercholesterolemia (HoFH) in CanadaZobaida Al-Baldawi, Armen Erzingatzian, Isabelle Ruel, et al.
Nature Communications|September 5, 2020
Chromosome 1q21.2 and additional loci influence risk of spontaneous coronary artery dissection and myocardial infarctionJacqueline Saw, Min-Lee Yang, Mark Trinder, et al.
JACC. Advances|January 24, 2026
Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH RegistryArmen Erzingatzian, Zobaida Al-Baldawi, Isabelle Ruel, et al.
The Canadian Journal of Cardiology|December 12, 2018
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018Liam R Brunham, Isabelle Ruel, Sumayah Aljenedil, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Journal of the American College of Cardiology|September 2, 2017
Optimizing Cholesterol Treatment in Patients With Muscle ComplaintsRobert S Rosenson, Steven Baker, Maciej Banach, et al.
JAMA Oncology|April 28, 2017
Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular CancerBritt I Drögemöller, Jose G Monzon, Amit P Bhavsar, et al.
American Heart Journal|May 5, 2024
Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYNStephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
The Canadian Journal of Cardiology|August 11, 2018
Simplified Canadian Definition for Familial HypercholesterolemiaIsabelle Ruel, Diane Brisson, Sumayah Aljenedil, et al.
Nature Medicine|April 17, 2026
Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trialStephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
Nature Medicine|February 27, 2026
Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trialStephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.
Atherosclerosis|June 2, 2026
Homozygous familial hypercholesterolemia (HoFH) in CanadaZobaida Al-Baldawi, Armen Erzingatzian, Isabelle Ruel, et al.
Nature Communications|September 5, 2020
Chromosome 1q21.2 and additional loci influence risk of spontaneous coronary artery dissection and myocardial infarctionJacqueline Saw, Min-Lee Yang, Mark Trinder, et al.
JACC. Advances|January 24, 2026
Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH RegistryArmen Erzingatzian, Zobaida Al-Baldawi, Isabelle Ruel, et al.
The Canadian Journal of Cardiology|December 12, 2018
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018Liam R Brunham, Isabelle Ruel, Sumayah Aljenedil, et al.
Pageof 16